Takahiro Irie, MD

Undergraduate
Department of Coloproctlogical Surgery, Juntendo University Faculty of Medicine
Juntendo University
Suginami-ku, Tokyo, Japan

2023- Present Medical Staff in Surgery, Department of Coloproctological Surgery, Juntendo University Hospital, Tokyo, Japan
2022-2023 Research trainee in Department of Epigenomics, Life Science Tokyo Advanced Research Center, Hoshi University, Japan
2021-2022 Research trainee in Division of Epigenomics, National Cancer Center Japan Research Institute, Tokyo, Japan
2020-2021 Medical Staff in Surgery, Department of Coloproctological Surgery, Juntendo University Hospital, Tokyo, Japan
2019-2020 Medical Staff in Surgery, Japanese Red Cross Musashino Hospital, Tokyo, Japan
2017-2019 Medical Staff in Surgery, Nitobe Memorial Nakano General Hospital, Tokyo, Japan
2015-2017 Resident, Japanese Red Cross Musashino Hospital, Tokyo, Japan

Disclosure information not submitted.

Presentation(s):

• SS02 - The Methylation Level of Circulating Tumor DNA Is a Prognostic Factor for Colorectal Cancer Patients

  Saturday, June 1, 2024
  3:13 PM – 3:21 PM ET, USA

• eP649 - Clinical Impact of Circulating Tumor DNA Methylation Status of Tumor Suppressor Genes in Precision Medicine for Stage IV Colorectal Cancer

  Monday, June 3, 2024
  1:57 PM – 2:02 PM ET, USA

• eP650 - The Effect of Overexpression of Regenerating Islet-derived type4 Isoform 2 on Colon Cancer Cell Proliferation

  Monday, June 3, 2024
  2:03 PM – 2:08 PM ET, USA